Titan Pharmaceuticals, Inc. Deferred Revenue
Titan Pharmaceuticals, Inc. had Deferred Revenue of $0 as of 2019-06-30, per its 10-Q filed 2019-08-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Deferred Revenue, Current
us-gaap:DeferredRevenueCurrent · last filed 2019-08-14
- 2019-06-30: Deferred Revenue, Current $0.00.
- 2019-03-31: Deferred Revenue, Current $0.00.
- 2018-12-31: Deferred Revenue, Current $313.00K.
- 2018-09-30: Deferred Revenue, Current $626.00K.
| Period end | Deferred Revenue, Current |
|---|---|
| 2019-06-30 | $0.00 10-Q · filed 2019-08-14 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-15 |
| 2018-12-31 | $313.00K 10-Q · filed 2019-08-14 |
| 2018-09-30 | $626.00K 10-Q · filed 2018-11-14 |
| 2018-06-30 | $939.00K 10-Q · filed 2018-08-14 |
| 2018-03-31 | $1.41M 10-Q · filed 2018-05-15 |
| 2017-12-31 | $0.00 10-K/A · filed 2019-04-02 |
| 2015-12-31 | $0.00 10-K · filed 2016-03-15 |
| 2015-09-30 | $0.00 10-Q · filed 2015-11-16 |
| 2015-06-30 | $0.00 10-Q · filed 2015-08-13 |
| 2015-03-31 | $760.00K 10-Q · filed 2015-05-13 |
| 2014-12-31 | $1.67M 10-K · filed 2016-03-15 |
| 2014-09-30 | $2.58M 10-Q · filed 2014-11-13 |
| 2014-06-30 | $3.49M 10-Q · filed 2014-08-13 |
| 2014-03-31 | $4.41M 10-Q · filed 2014-05-14 |
| 2013-12-31 | $5.32M 10-K · filed 2015-03-31 |
| 2013-09-30 | $6.23M 10-Q · filed 2013-11-14 |
| 2013-06-30 | $8.43M 10-Q · filed 2013-08-14 |
| 2013-03-31 | $10.63M 10-Q · filed 2013-05-15 |
| 2012-12-31 | $14.38M 10-K · filed 2014-03-31 |
| 2012-09-30 | $1.70M 10-Q · filed 2012-11-09 |
| 2011-12-31 | $0.00 10-K · filed 2013-03-18 |